WELDING PHARMA FDF – what we do for you

Clinical Development

No study, no market! The successful approval of a drug is often closely linked to the clinical review of FDF development projects.

Therefore, planning and coordinating clinical trials involves not only patience and time, but also a lot of work. We are supported in this by selected Clinical Research Organisations (CROs).

We identify the right external expertise for the respective finished drug formulation. Our WELDING development team is responsible for managing the CROs and planning the respective design for the clinical trials.

In this way, we ensure that the clinical data required for the approval of a development project are available on time.

In addition, our developers are responsible for the fulfilment and documentation of all legal and regulatory requirements in connection with the planning and execution of clinical trials. In-house clinical development also ensures that clinical data is recognised.


Welding contact

Pharmaceutical Know - How by WELDING

Contact us with your queries and we can suggest potential solutions.